Dac590 is an orally active FTO inhibitor. Dac590 has a robust antiproliferative effect on AML cells, and induces apoptosis and cell cycle G1 arrest by inhibiting oncogenic FTO signaling. Dac590 significantly inhibits tumor growth and prolongs survival with no observed toxicity in acute myeloid leukemia (AML) xenograft mcie model, and shows a synergistic effect combined with Decitabine (HY-A0004)[1].
Molecular Weight:
390.79
Purity:
96.15
CAS Number:
[3084407-00-8]
Formula:
C19H16ClFN2O4
Target:
Apoptosis,Fat Mass and Obesity-associated Protein (FTO)
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
